Standout Papers
- Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure (2024)
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (2024)
- The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 (2019)
- Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial (2024)
Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Works of Karla Hurt being referenced
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
2019 Standout
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Karla Hurt | 672 | 636 | 189 | 286 | 24 | 1.2k | |
| Nisha Nanda | 232 | 554 | 163 | 281 | 33 | 1.3k | |
| M Koss | 370 | 528 | 190 | 233 | 28 | 1.5k | |
| Juan C. Osorio | 624 | 552 | 315 | 459 | 43 | 1.7k | |
| Kiyoshi Fujinami | 244 | 438 | 139 | 548 | 45 | 1.2k | |
| Swaminathan Murugappan | 374 | 197 | 341 | 334 | 27 | 1.3k | |
| Beverly L. Falcón | 424 | 212 | 131 | 789 | 34 | 1.3k | |
| James R. Dilks | 286 | 415 | 114 | 625 | 21 | 1.4k | |
| Joanna M. Brell | 1175 | 495 | 132 | 419 | 40 | 1.7k | |
| Ann M. McNulty | 427 | 443 | 60 | 964 | 32 | 1.7k | |
| Shuichi Aoki | 529 | 244 | 143 | 177 | 51 | 1.0k |
All Works
Loading papers...